Rochester, NY 8/27/2009 9:28:46 PM
News / Finance

Merck & Co. Inc. MRK Stock Market Update down at 1.07%

Merck & Co. Inc.

Merck & Co. Inc. had opened at 32.60 but quickly falling down to 0.35 cents and still holding on to that. The company is doing a heavy trading at 17 million under a 3 month average.

Merck & Co., Inc. provides products for human and animal health in the United States and internationally. The company’s Pharmaceutical segment offers human health pharmaceutical products, such as therapeutic and preventive agents

http://StockEinstein.com offers free daily stock alerts on companies ready to run.  Scroll to BOTTOM of this page for free stock alerts, or visit our site.

Last Trade:      32.33       
Day's Range:    32.26-32.60       
52wk Range:     20.05-36.57       
Change:            Down 0.35(1.07%)
Volume:            1,354,514
Avg Vol (3m):   18,846,300

About Merck & Co. Inc.

Merck & Co., Inc. provides products for human and animal health in the United States and internationally. The company’s Pharmaceutical segment offers human health pharmaceutical products, such as therapeutic and preventive agents. Its products comprise Singulair, a leukotriene receptor antagonist for the treatment of asthma and allergic rhinitis; Cozaar, Hyzaar, Vasotec, and Vaseretic, the hypertension and/or heart failure products; Fosamax and Fosamax Plus D for treating osteoporosis; Januvia and Janumet for type 2 diabetes; Cosopt and Trusopt, the ophthalmological products; Zocor, an atherosclerosis product; Maxalt for acute migraine; Propecia to treat male pattern hair loss; Arcoxia to treat arthritis and pain; Proscar to treat symptomatic benign prostate enlargement; and Emend for the prevention of chemotherapy-induced and post-operative nausea and vomiting. Merck & Co.’s Vaccines segment comprises human health vaccines, such as preventative pediatric, adolescent, and adult vaccines. Its products include
Gardasil to prevent cervical cancer, pre-cancerous and low-grade lesions, vulvar and vaginal pre-cancers, and genital warts; Varivax to prevent chickenpox; ProQuad, a pediatric combination vaccine against measles, mumps, rubella, and varicella; M-M-R II, a vaccine against measles, mumps, and rubella; RotaTeq to protect against rotavirus gastroenteritis in children; Zostavax for preventing shingles; Primaxin and Cancidas, anti-bacterial/anti-fungal products; Isentress, Crixivan, and Stocrin, antiretroviral therapies for the treatment of HIV infection; and Invanz for the treatment of infection. Merck & Co. has research, collaboration, or licensing agreements with Neuromed Pharmaceuticals, Ltd.; ARIAD Pharmaceuticals, Inc.; GTX, Inc.; Idera Pharmaceuticals; Japan Tobacco Inc.; Galapagos NV; AstraZeneca plc; Metabasis Therapeutics Inc.; and Addex Pharmaceuticals Ltd. The company was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.

About Stock Einstein

StockEinstein uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance.  We utilize not only software, but time tested criteria to uncover these potential winners.  When these benchmarks are reached or exceeded, our subscribers are immediately notified.

This service is free and available only to subscribers. 
Scroll to the bottom of this page to signup for free stock alerts and visit our site.

Disclaimer: Full disclaimer at http://StockEinsteain.com/disclaimer.php

IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment.  Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses.  Neither StockEinsteain, nor any of its affiliates are registered investment advisors or broker dealers.